Low Dose Naltrexone for Glioma Patients

Clinical trial NCT01303835 · COMPLETED

Trial details

NCT number: NCT01303835
Sponsor: Katy Peters
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Glioma

Start date: 2011-05-01
Primary completion: 2014-06-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.